Business Context and Reporting Period
This Form 8-K is filed by Derycz Scientific, Inc. (not Research Solutions, Inc.) for the reporting period ending November 17, 2010. The filing reports on unregistered sales of equity securities pursuant to Item 3.02.
Key Financial Metrics and Transaction Details
- Cash Proceeds: The Company received $1,857,812.50 from the cash exercise of December 2006 Warrants.
- Shares Issued (Cash Exercise): 1,486,250 shares of common stock were issued.
- Shares Issued (Cashless Exercise): 8,199 shares of common stock were issued.
- Exercise Price (Original Warrants): $1.25 per share.
- Exercise Price (New Warrants): $2.00 per share.
- Use of Proceeds: General working capital purposes.
Material Changes and Transaction Structure
On November 12, 2010, the Board accepted an unsolicited offer from holders of December 2006 Warrants. Under this arrangement, holders exercised their warrants for cash in exchange for the issuance of "New Warrants."
- New Warrant Terms: For every share obtained via the original warrant exercise, the Company issued a New Warrant exercisable for one-half that number of shares.
- Current Status: As of November 17, 2010, 20 New Warrants were issued, representing the right to purchase 743,125 shares.
- Remaining Original Warrants: 26 December 2006 Warrants remain outstanding, representing the right to purchase 938,750 shares. These expire on December 22, 2010.
- Maximum Potential Dilution: If all remaining December 2006 Warrants are exercised under these terms, up to 1,212,500 additional shares could be issued via New Warrants.
Outlook, Risks, and Contingencies
- Registration Status: Neither the New Warrants nor the underlying shares are currently registered under the Securities Act of 1933. The Company intends to register the underlying shares during 2011 but faces no penalties for failure to do so.
- Uncertainty of Future Exercises: The Company cannot determine or control how many of the remaining December 2006 Warrants will be exercised under the new terms.
- Expiration Risk: The December 2006 Warrants expire on December 22, 2010, creating a short window for potential additional capital raises or dilution.
Investor Verification Checklist
- Verify the exact number of remaining December 2006 Warrants and the likelihood of their exercise before the December 22, 2010 expiration.
- Confirm the timeline and success of the Company's plan to register the shares underlying the New Warrants in 2011.
- Assess the impact of potential dilution from the maximum 1,212,500 shares issuable via New Warrants.
- Review the Company's cash position to ensure the $1.86 million proceeds are sufficient for stated working capital needs.